Masimo Corporation

IRVINE, Calif., May 3, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced it has signed a three-year, dual-source agreement with Novation, the healthcare contracting services company of VHA Inc. and the University Health System Consortium (UHC). The agreement, effective May 1, 2012, covers Masimo SET® pulse oximetry ... read more

IRVINE, Calif., May 2, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced its financial results for the first quarter ended March 31, 2012. Masimo's total first quarter revenue, including royalties, rose 6% to $119.2 million, compared to $113.0 million for the first ... read more

IRVINE, Calif., March 26, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI), the inventor of rainbow Pulse CO-Oximetry(TM), rainbow Acoustic Monitoring(TM), and Masimo SET® Measure-Through Motion and Low Perfusion pulse oximetry, debuted its 2012 Radical-7 monitor at the 15th World Congress of Anaesthesiologists conference in Buenos Aires, Argentina, March 25-30, 2012. (Photo: ... read more

IRVINE, Calif., Feb. 14, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced that in line with its mission to "Improve Patient Outcomes and Reduce the Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications®," and its confidence that continuous noninvasive hemoglobin monitoring (SpHb®) ... read more

IRVINE, Calif., Jan. 9, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced FDA 510(k) clearance and full market commercial launch of the Masimo Pronto-7®--a palm-sized handheld device designed for quick and easy noninvasive spot-checking of total hemoglobin (SpHb®), SpO2, pulse rate, and perfusion index. (Photo: ... read more